Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BKM120 in Recurrent Glioblastoma
NCT01339052Phase 2Completed
- Sponsor
- L. Nicolas Gonzalez Castro
- Start
- Sep 2011
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of buparlisib in glioblastoma (GBM), sponsored by L. Nicolas Gonzalez Castro. Started Sep 2011; status: completed.
02
Drugs
buparlisib
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT01339052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01339052.